Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Instil Bio, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of TIL: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders6258−4
Shares82.1M80.2M−1.93M (−2.4%)
Value$45.3M$34.3M−$10.9M (−24.1%)

New holders (9)

Institutions that held Instil Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to TIL in Q3 2023
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC1,000,000$428.0K0.05%
Barclays PLC353,036$151.1K0.00%
Ieq Capital, LLC120,000$51.4K0.00%
Beacon Pointe Advisors, LLC96,999$41.5K0.00%
Two Sigma Securities, LLC41,696$17.8K0.00%
HCR Wealth Advisors40,000$17.1K0.00%
Jane Street Group, LLC39,739$17.0K0.00%
Landscape Capital Management, L.L.C.38,245$16.4K0.00%
XTX Topco Ltd12,413$5.31K0.00%

Sold out (13)

Institutions that held Instil Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.